Blog

Like other renewable energy stocks, TPI Composites (NASDAQ: TPIC) had a great 2020. But it's been a rough ride so far in 2021. Although shares are now about even for the year, they were up over 45%

Identity management specialist Okta (NASDAQ: OKTA) has been a tremendous winner for shareholders. Investors who have held the stock for three years have been rewarded with an amazing six-bagger

In the past year we have witnessed an explosion of institutional support for Bitcoin and other cryptocurrencies. Major companies like Square and PayPal Holdings have embraced Bitcoin. Even legacy

The Russell 2000 is not exactly an unknown index, as it is often used as a proxy for small-cap stocks, but it grabs far fewer headlines than the S&P 500, which tracks the market's 500 largest

Capital One Financial (NYSE: COF) is one of the largest banks in the country in terms of assets, with about $363 billion under management as of the end of 2020. While it does have branches

The food delivery industry is growing rapidly. Accelerated by the pandemic, U.S. food delivery revenue hit $26.5 billion in 2020, up 204% over the last five years, and that figure is projected to

Warren Buffett is regarded as one of the world's quintessential value investors. Following the teachings of his business school professor Benjamin Graham, Buffett has made a legendary career for

When you apply for a loan, most lenders will check your credit score and verify your income. But not Upstart Holdings (NASDAQ: UPST). The company uses more than 1,000 data points in its artificial

The U.S. Food and Drug Administration (FDA) has now pushed back two reviews for regulatory filings by AbbVie (NYSE: ABBV) for Rinvoq. This autoimmune disease drug is an important component of the

Illumina (NASDAQ: ILMN) delivered a pleasant surprise earlier this month with its revenue growth projected for the first quarter and for full-year 2021. In this Motley Fool Live video recorded on

Zomedica (NYSEMKT: ZOM) has been one of the hottest stocks of 2021, soaring more than 340% this year and dwarfing the S&P 500 and its 10% gains in the process. At one point it was up more than 900%

On March 1, Morphic Holding's (NASDAQ: MORF) stock more than doubled after the company announced interim phase 1 data on its experimental therapy, MORF-057. That's a pretty significant pop for an

How heavily will you depend on Social Security in retirement? The extent to which you do will hinge on different factors, like how much savings you amass by that point.

But either way, you'd

When a stock goes up or down a lot in a short amount of time, it's easy to think something has changed. That volatility can often be a distraction. The most successful investors are able to focus on

Office real estate investment trusts (REITs) have struggled over the past year as COVID-19-driven shutdowns have increased vacancy rates and tenant delinquencies. Retail spaces within these

There aren't many stocks out there that pay you dividends on a monthly basis. That doesn't mean it's impossible to generate recurring monthly cash flow for your portfolio. One way you can accomplish

It's a remarkable time to be an investor. Over the past year, the market has not only recovered its losses from the coronavirus crash, but marked multiple days of new thrilling highs.

The stock

Like most of the other COVID-19 vaccines that have already won Emergency Use Authorization (EUA), Novavax's (NASDAQ: NVAX) vaccine requires two shots spread several weeks apart. But the biotech

bluebird bio (NASDAQ: BLUE) ran into some issues with manufacturing its gene therapy, and then the drugmaker was sideswiped by the possibility that its treatment might cause cancer. In this video

What do a leading data analytics company and a licensed cannabis producer have in common?

Although not much can be found at a mere glance, dig deeper and you will find two growth stocks riding solid

Over the past 12 months, the S&P 500 has delivered an impressive 48% return. However, the index is now at its third most-expensive level in history, with a price-to-earnings (P/E) ratio of 42.

With

When the COVID-19 pandemic swept across the world a little over a year ago, most businesses that focused on in-person services, events, and gatherings, as well as any adjacent activities, were

The pandemic has boosted businesses that have been able to adapt and evolve their business models to cope with the challenges. Some companies have been resourceful in pivoting toward online sales

When I look at the strongest performers in my own portfolio, I often see powerful moats.

Intuitive Surgical (NASDAQ: ISRG) is a beautiful example of a razor-and-blades company in the healthcare

Some stock traders have short attention spans. Shares can have dramatic rises over the course of months, only to be forgotten at the first sign of trouble. This is especially true in the biotech